HILLARY CLARK: Open Payments
NPI 1720591076 · LONDON, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,289 in 85 payments from 24 companies in 2025. Trend: 2023 $2,388 · 2024 $2,871 · 2025 $1,289
Food & beverage: $1,289
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 41 | $479 |
| Alexion Pharmaceuticals, Inc. | 4 | $94 |
| Lilly USA, LLC | 3 | $63 |
| ARGENX US, INC. | 4 | $62 |
| Lundbeck LLC | 3 | $61 |
| EMD Serono, Inc. | 3 | $59 |
| PFIZER INC. | 4 | $58 |
| UCB, Inc. | 3 | $53 |
| TG Therapeutics, Inc. | 2 | $38 |
| Vanda Pharmaceuticals Inc. | 2 | $38 |
Products named: QULIPTA, BOTOX, UBRELVY, ULTOMIRIS, AMYVID, VYVGART, VYEPTI, NURTEC ODT.
Industry payments across KY — which companies pay providers there.
